MedPath

A double-blind, randomised, controlled multicentre trial of three misoprostol regimens after pretreatment with mifepristone for termination of early pregnancy

Completed
Conditions
Abortion
Induced abortion
Pregnancy and Childbirth
Registration Number
ISRCTN81170837
Lead Sponsor
DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction (HRP)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
2100
Inclusion Criteria

1. Healthy women
2. Eligible for and requesting medical abortion
3. Prepared to terminate the pregnancy should the treatment fail

Exclusion Criteria

No exclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath